Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
January 02, 2025 10:55 ET
|
Aptorum Group Ltd
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical...